- •Diabetic Retinopathy
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •Pathophysiology of Diabetic Retinopathy
- •1.1 Retinal Anatomy
- •1.1.1 History
- •1.1.2 Anatomy
- •1.1.3 Microanatomy of the Retina Neurons
- •1.1.4 Intercellular Spaces
- •1.1.5 Internal Limiting Membrane
- •1.1.6 Circulation
- •1.1.7 Arteries
- •1.1.8 Veins
- •1.1.9 Capillaries
- •1.2 Hemodynamics, Macular Edema, and Starling’s Law
- •1.3 Biochemical Basis for Diabetic Retinopathy
- •1.3.1 Increased Polyol Pathway Flux
- •1.3.2 Advanced Glycation End Products (AGEs)
- •1.3.3 Activation of Protein Kinase C (PKC)
- •1.3.4 Increased Hexosamine Pathway Flux
- •1.4 Macular Edema
- •1.5 Development of Proliferative Diabetic Retinopathy
- •1.6 Summary of Key Points
- •1.7 Future Directions
- •References
- •Genetics and Diabetic Retinopathy
- •2.1 Background for Clinical Genetics
- •2.2 The Role of Polymorphisms in Genetic Studies
- •2.3 Types of Genetic Study Design
- •2.4 Studies of the Genetics of Diabetic Retinopathy
- •2.4.1 Clinical Studies
- •2.4.2 Molecular Genetic Studies
- •2.4.3 EPO Promoter
- •2.4.4 Aldose Reductase Gene
- •2.4.5 VEGF Gene
- •2.5 Genes in or Near the HLA Locus
- •2.6 Receptor for Advanced Glycation End Products (RAGE) Genes
- •2.7 Endothelial NOS2 and NOS3 Genes
- •2.9 Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 1 Gene (SLC2A1)
- •2.11 Potential Value of Identifying Genetic Associations with Diabetic Retinopathy
- •2.12 Summary of Key Points
- •2.13 Future Directions
- •Glossary
- •References
- •Epidemiology of Diabetic Retinopathy
- •3.1 Introduction and Definitions
- •3.2 Epidemiology of Diabetes Mellitus
- •3.3 Factors Influencing the Prevalence of Diabetes Mellitus
- •3.4 Epidemiology of Diabetic Retinopathy
- •3.5 Diabetes and Visual Loss
- •3.6 Prevalence and Incidence of Diabetic Retinopathy
- •3.7 By Diabetes Type
- •3.8 By Insulin Use
- •3.10 By Duration of Diabetes Mellitus
- •3.11 By Ethnicity
- •3.12 Gender
- •3.13 Age at Onset of Diabetes
- •3.14 Socioeconomic Status and Educational Level
- •3.15 Family History of Diabetes
- •3.16 Changes Over Time
- •3.17 Epidemiology of Diabetic Macular Edema (DME)
- •3.18 Epidemiology of Proliferative Diabetic Retinopathy (PDR)
- •3.19 Socioeconomic Impact of Diabetes
- •3.20 Socioeconomic Impact of Diabetic Retinopathy
- •3.21 Summary of Key Points
- •3.22 Future Directions
- •References
- •Systemic and Ocular Factors Influencing Diabetic Retinopathy
- •4.1 Introduction
- •4.2 Systemic Factors
- •4.2.1 Glycemic Control
- •4.2.1.1 Type 1 Diabetes Mellitus
- •4.2.1.2 Type 2 Diabetes Mellitus
- •4.2.1.3 Rapidity of Improvement in Glycemic Control
- •4.2.2 Glycemic Variability
- •4.2.3 Insulin Use in Type 2 Diabetes
- •4.2.5 Blood Pressure
- •4.2.6 Serum Lipids
- •4.2.7 Anemia
- •4.2.8 Nephropathy
- •4.2.9 Pregnancy
- •4.2.10 Other Systemic Factors
- •4.2.11 Influence on Visual Loss
- •4.3 Effects of Systemic Drugs
- •4.3.1 Diuretics
- •4.3.3 Aldose Reductase Inhibitors
- •4.3.4 Drugs That Target Platelets
- •4.3.5 Statins
- •4.3.6 Protein Kinase C Inhibitors
- •4.3.7 Thiazolidinediones (Glitazones)
- •4.3.8 Miscellaneous Drugs
- •4.4 Ocular Factors Influencing Diabetic Retinopathy
- •4.6 Economic Consequences
- •4.7 Summary of Key Points
- •4.8 Future Directions
- •References
- •Defining Diabetic Retinopathy Severity
- •5.1 Summary of Key Points
- •5.2 Future Directions
- •5.3 Practice Exercises
- •References
- •6.1 Optical Coherence Tomography (OCT)
- •6.2 Heidelberg Retinal Tomograph (HRT)
- •6.3 Retinal Thickness Analyzer (RTA)
- •6.4 Microperimetry
- •6.5 Color Fundus Photography
- •6.6 Fluorescein Angiography
- •6.7 Ultrasonography
- •6.8 Multifocal ERG
- •6.9 Miscellaneous Modalities
- •6.10 Summary of Key Points
- •6.11 Future Directions
- •6.12 Practice Exercises
- •References
- •Diabetic Macular Edema
- •7.1 Epidemiology and Risk Factors
- •7.2 Pathophysiology and Pathoanatomy
- •7.2.1 Anatomy
- •7.3 Physiology
- •7.4 Clinical Definitions
- •7.5 Focal and Diffuse Diabetic Macular Edema
- •7.6 Subclinical Diabetic Macular Edema
- •7.7 Refractory Diabetic Macular Edema
- •7.8 Regressed Diabetic Macular Edema
- •7.9 Recurrent Diabetic Macular Edema
- •7.10 Methods of Detection of Diabetic Macular Edema
- •7.11 Case Report 1
- •7.12 Case Report 2
- •7.13 Other Ancillary Studies in Diabetic Macular Edema
- •7.14 Natural History
- •7.15 Treatments
- •7.15.1 Metabolic Control and Effects of Drugs
- •7.16 Focal/Grid Laser Photocoagulation
- •7.16.1 ETDRS Treatment of CSME
- •7.17 Evolution in Focal/Grid Laser Treatment Since the ETDRS
- •7.18 Macular Thickness Outcomes After Focal/Grid Photocoagulation
- •7.19 Resolution of Lipid Exudates After Focal/Grid Laser Photocoagulation
- •7.20 Inconsistency in Defining Refractory Diabetic Macular Edema
- •7.21 Alternative Forms of Laser Treatment for Diabetic Macular Edema
- •7.22 Peribulbar Triamcinolone Injection
- •7.23 Intravitreal Triamcinolone Injection
- •7.24 Intravitreal Dexamethasone Delivery System
- •7.27 Combined Intravitreal and Peribulbar Triamcinolone and Focal Laser Therapy
- •7.28 Vitrectomy
- •7.29 Supplemental Oxygen and Hyperbaric Oxygenation
- •7.30 Resection of Subfoveal Hard Exudates
- •7.31 Subclinical Diabetic Macular Edema
- •7.32 Cases with Simultaneous Indications for Focal and Scatter Laser Photocoagulation
- •7.34 Factors Influencing Treatment of Diabetic Macular Edema
- •7.35 Sequence of Therapy
- •7.36 Interaction of Cataract Surgery and Diabetic Macular Edema
- •7.37 Summary of Key Points
- •7.38 Future Directions
- •References
- •Diabetic Macular Ischemia
- •8.1 Introduction
- •8.2 Pathogenesis, Anatomy, and Physiology
- •8.3 Natural History
- •8.4 Clinical Evaluation
- •8.5 Clinical Significance of Diabetic Macular Ischemia
- •8.6 Controversies and Conundrums
- •8.7 Summary of Key Points
- •8.8 Future Directions
- •References
- •Treatment of Proliferative Diabetic Retinopathy
- •9.1 Introduction
- •9.2 Laser Photocoagulation
- •9.2.1 Indications
- •9.2.2 PRP Technique
- •9.2.3 Complications
- •9.2.4 Outcome
- •9.3 Intraocular Pharmacological Therapy
- •9.4 Vitreoretinal Surgery
- •9.4.1 Indications
- •9.4.2 Preoperative Management
- •9.4.3 Instrumentation
- •9.4.4 Techniques
- •9.4.5 Postoperative Management
- •9.4.6 Complications
- •9.4.7 General Outcome
- •9.5 Follow-Up Considerations in PDR
- •9.6.1 Cataract and PDR
- •9.6.2 Dense Vitreous Hemorrhage and Untreated PDR
- •9.6.3 Untreated PDR with Diabetic Macular Edema
- •9.6.4 PDR with Severe Fibrovascular Proliferation/Traction Retinal Detachment
- •9.6.5 PDR with Neovascular Glaucoma
- •9.6.6 Conditions Altering the Clinical Course of PDR
- •9.7 Summary of Key Points
- •9.8 Future Directions
- •References
- •Cataract Surgery and Diabetic Retinopathy
- •10.1 Scope of the Problem of Diabetic Retinopathy Concomitant with Surgical Cataract
- •10.2 Visual Outcomes After Cataract Surgery in Patients with Diabetic Retinopathy
- •10.3 Postoperative Course and Special Considerations After Cataract Surgery in Patients with Diabetic Retinopathy
- •10.4 The Influence of Cataract Surgery on Diabetic Retinopathy
- •10.5 The Role of Ancillary Testing in Managing Cataract Surgery in Eyes with Diabetic Retinopathy
- •10.6 Candidate Risk and Protective Factors for Diabetic Macular Edema Induction or Exacerbation Following Cataract Surgery and Suggested Management Actions
- •10.7 The Problem of Adherence to Preferred Practice Guidelines
- •10.8 Management of the Diabetic Eye Without Macular Edema About to Undergo Cataract Surgery
- •10.9 Treatment of Diabetic Macular Edema Detected Before Cataract Surgery When the Macular View Is Clear
- •10.10 Management When Cataract Sufficient to Obscure the Macular View and DME Coexist or When Refractory DME and Cataract Coexist
- •10.11 Patients with Simultaneous Indications for Panretinal Photocoagulation and Cataract Surgery
- •10.12 Management of Cataract in Patients with Diabetic Retinopathy Undergoing Vitrectomy
- •10.13 Influence of Vitrectomy Surgery on Cataract Formation
- •10.15 Postoperative Endophthalmitis in Patients with Diabetic Retinopathy
- •10.16 Summary of Key Points
- •10.17 Future Directions
- •References
- •The Relationship of Diabetic Retinopathy and Glaucoma
- •11.1 Interaction of Diabetes and Glaucoma
- •11.2 Iris and Angle Neovascularization Pathoanatomy and Pathophysiology
- •11.3 Epidemiology
- •11.4 Clinical Detection
- •11.5 Classification
- •11.6 Risk Factors for Iris Neovascularization
- •11.7 Entry Site Neovascularization After Pars Plana Vitrectomy
- •11.8 Anterior Hyaloidal Fibrovascular Proliferation
- •11.9 Treatments for Iris Neovascularization
- •11.10 Modifiers of Behavior of Iris Neovascularization
- •11.11 Management of Neovascular Glaucoma
- •11.12 Summary of Key Points
- •11.13 Future Directions
- •References
- •The Cornea in Diabetes Mellitus
- •12.1 Introduction
- •12.2 Pathophysiology
- •12.3 Anatomy and Morphological Changes
- •12.4 Clinical Manifestations
- •12.5 Ocular Surgery
- •12.6 Treatment of Corneal Disease in Diabetes Mellitus
- •12.7 Conclusion
- •12.8 Summary of Key Points
- •12.9 Future Directions
- •References
- •Optic Nerve Disease in Diabetes Mellitus
- •13.1 Relevant Normal Optic Nerve Anatomy and Physiology
- •13.2 The Effect of Diabetes on the Optic Nerve
- •13.3 Nonarteritic Anterior Ischemic Optic Neuropathy and Diabetes
- •13.4 Diabetic Papillopathy
- •13.5 Disk Edema Associated with Vitreous Traction
- •13.6 Superior Segmental Optic Hypoplasia (Topless Optic Disk Syndrome)
- •13.7 Wolfram Syndrome
- •13.8 Summary of Key Points
- •13.9 Future Directions
- •References
- •Screening for Diabetic Retinopathy
- •14.1 Introduction
- •14.2 Who Does Not Need to Be Screened
- •14.5 Screening with Dilated Ophthalmoscopy by Ophthalmic Technicians or Optometrists
- •14.6 Screening with Dilated Ophthalmoscopy by Ophthalmologists
- •14.7 Screening with Dilated Ophthalmoscopy by Retina Specialists
- •14.8 Photographic Screening
- •14.9 Nonmydriatic Photography
- •14.10 Mydriatic Photography
- •14.11 Risk Factors for Ungradable Photographs
- •14.12 Number of Photographic Fields
- •14.13 Criteria for Referral
- •14.14 Obstacles to the Use of Teleophthalmic Screening Methods
- •14.15 Combination Methods of Screening
- •14.16 Case Yield Rates
- •14.17 Compliance with Recommendation to Be Seen by an Ophthalmologist
- •14.18 Intravenous Fluorescein Angiography and Oral Fluorescein Angioscopy
- •14.19 Automated Fundus Image Interpretation
- •14.20 Subgroups Needing Enhanced Screening Efforts
- •14.21 Screening in Pregnancy
- •14.22 Economic Considerations
- •14.23 Comparisons of the Screening Methods
- •14.24 Accountability of Screening Programs
- •14.25 Summary of Key Points
- •14.26 Future Directions
- •References
- •Practical Concerns with Ethical Dimensions in the Management of Diabetic Retinopathy
- •15.1 Incorporating Ancillary Testing in the Management of Patients with Diabetic Retinopathy
- •15.2.1 Case 1
- •15.2.2 Case 2
- •15.4 Working in a Managed Care Environment (Capitation)
- •15.5 Interactions with Medical Industry
- •15.7 Comanagement of Patients
- •15.9 Summary of Key Points
- •15.10 Future Directions
- •References
- •Clinical Examples in Managing Diabetic Retinopathy
- •16.1.1 Discussion
- •16.2 Case 2: Bilateral Proliferative Diabetic Retinopathy with Acute Vitreous Hemorrhage in One Eye and a Chronic Traction Retinal Detachment in the Other Eye
- •16.2.1 Discussion
- •16.2.2 Opinion 1
- •16.2.3 Opinion 2
- •16.2.4 Opinion 3
- •16.3 Case 3: Sight Threatening Diabetic Retinopathy in a Patient with Concomitant Medical and Socioeconomic Problems
- •16.3.1 Discussion
- •16.4 Case 4: Asymptomatic Retinal Detachment Following Vitrectomy in a Patient Who Has Had Panretinal Laser Photocoagulation
- •16.4.1 Discussion
- •16.5 Case 5: Management of Progressive Vitreous Hemorrhage Following Scatter Photocoagulation for Proliferative Diabetic Retinopathy
- •16.5.1 Discussion
- •16.6.1 Discussion
- •16.7 Case 7: Proliferative Diabetic Retinopathy with Macular Traction and Ischemia
- •16.7.1 Discussion
- •16.8 Case 8: What Is Maximal Focal/Grid Laser Photocoagulation for Diabetic Macular Edema?
- •16.8.1 Definition of the Problem
- •16.8.2 Discussion
- •16.9 Case 9: What Independent Information Does Macular Perfusion Add to Patient Management in Diabetic Retinopathy?
- •16.9.1 Discussion
- •16.10 Case 10: Macular Edema Following Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
- •16.10.1 Discussion
- •16.11 Case 11: Diabetic Macular Edema with a Subfoveal Scar
- •16.11.1 Discussion
- •16.12.1 Definition of the Problem
- •16.12.2 Discussion
- •16.13.1 Definition of the Problem
- •16.13.2 Discussion
- •16.14 Case 14: How Is Diabetic Macular Ischemia Related to Visual Acuity?
- •16.14.1 Definition of the Problem
- •16.14.2 Discussion
- •References
- •Subject Index
1 Pathophysiology of Diabetic Retinopathy |
5 |
|
|
360 ð5:5=circumference of eyeÞ ¼ 26:18 :
One-half the straightened image height (i/2) can be calculated by
tanð13:09Þ ¼ ði=2Þ=12:035 leading to the image height of i ¼ 2 12:035 tanð13:09Þ ¼ 5:56 mm:
The simplified version of the eye is that of a single lens of 17 mm in front of the retina (the eye’s nodal point). Ray tracing shows the relationship between object and image in Fig. 1.2. One-half the angle (a/2) subtended by the image from the eyes nodal point can be calculated by
tanða=2Þ ¼ 2:78=17;
where
a = 2 arc tan(2.78/17) = 18.578.
The ora serrata – named for its marginal notches – forms the peripheral edge of the retina as the junction between the multilayered optical retina and the monolayered, nonpigmented epithelium of the ciliary body. The anatomic characteristics of this region are due to its thinness, avascularity, and close relationship to the vitreous base and zonular fibers. The vitreous base normally extends from 2 to 4 mm posterior to the ora. The vitreous cortex collagen fibrils insert into the internal limiting membrane of the retina. Vitreoretinal adhesion is particularly strong along the posterior margin of the vitreous base, making this a common site for retinal tears. As the retina approaches the ora there is gradual loss of the nerve fiber layer, ganglion cell layer, and plexiform layers. These layers are replaced with neuroglia and Muller’s cells, which serve as structural support for the entire retina. Both the ILM, into which vitreous base inserts, and the ELM, which continues between the pigmented and nonpigmented layers of pars plana, are thickened.
1.1.3 Microanatomy of the Retina Neurons
The cells within the retina fall into one of three groups: neuronal, glial, and vascular. The neural cells give the retina its primary function: converting light energy into electrical signals. This is
accomplished through intricate interaction between the three types of neural cells: photoreceptors, interneurons, and ganglion cells. The photoreceptor cells, the rods and cones, are the primary neurons in the visual pathway. The dense packing of the photoreceptors, combined with their precise axial arrangement, provides for detection of individual photons and the accurate construction of an image. Any change from this axial arrangement causes alteration in vision: micropsia if the cells are abnormally separated, such as with subretinal fluid; metamorphopsia if the alignment is lacking; loss of acuity if the axial alignment is sufficiently disturbed so that the photoreceptor is no longer axial to the inciting light.
The cone cells are comprised of four portions: inner segments, outer segments containing the visual pigment, a perikaryal region containing the cell nucleus, and a synaptic terminal. The light-absorbing visual pigment in rods, rhodopsin, is composed of the light-sensitive chromophore retinal, which is attached to the protein opsin.7 This is most sensitive to light with a wavelength of 500 nm. The three different types of cones each contains one lightsensitive pigment, resulting in three different spectral sensitivities. The blue, green, and yellow cone pigments are maximally absorbent at 450, 530, and 565 nm, respectively.
The photoreceptor outer segments have two important connections: to the inner segments (cell bodies of the photoreceptors) and to the
6 |
M.W. Stewart |
|
|
extracellular matrix, which separates it from the retinal pigment epithelium. The matrix is synthesized by both the photoreceptors and RPE.8 The acid mucopolysaccharides of the matrix are likely synthesized in the photoreceptor inner segments; disturbances of this would result in separation of photoreceptors from RPE, such as in an exudative retinal detachment. The nuclei of the cones form the outer nuclear layer and lie 3–4 mm internal to the outer limiting membrane. The photoreceptors form junctions with interneurons and Muller cells; the plasma membrane of each photoreceptor and Muller cell is differentiated into a dense band known as the outer limiting membrane. Rods and cones do not contact each other; they are insulated from each other by the Muller cells. The Muller cells contact each other in zonulae adherentes, which are thought to form a diffusion barrier between the intercellular space of the inner retina and the extracellular matrix between the photoreceptor outer segments and the pigment epithelium.
The outer plexiform layer lies between the inner and outer nuclear layers. The synaptic zone, with numerous intercellular junctions and synapses between neural and glial processes, creates the middle limiting membrane. This resembles the outer limiting membrane and may act as a partial barrier to diffusion of fluid and larger molecules. Exudates, hemorrhages, and cysts may be prevented from spreading through the entire retina.
The inner plexiform layer is located between the ganglion and inner nuclear cell layers. In addition to Muller cell branches and retinal blood vessels, it contains synaptic processes of the bipolar, ganglion, and amacrine cells. There are an enormous number of synapses within the inner plexiform layer – 2.9 million dyads (a dyad is a synaptic pair) per square millimeter.9 Each dyad consists of a bipolar cell making contact with two processes: one from a ganglion cell and the other from an amacrine cell.
The ganglion cell bodies form a distinct layer between the inner plexiform layer and the nerve fiber layer. Through much of the retina there is 1 ganglion cell for every 100 rods and 4–6 cones; however, in the macula the ganglion cell-to-photo- receptor ratio is higher, creating a smaller receptor field for each ganglion cell and, therefore, greater image resolution. Though there are no ganglion cells at the foveal center, the ganglion cells are so
densely packed within the macula that there may be two or more for every cone.10 There are two major groups of ganglion cells: midget and diffuse. The midget ganglion cells cover small areas (<10 mm2) and synapse with only one midget bipolar cell, though each midget bipolar cell may synapse with numerous ganglion cells. On the other hand are the diffuse ganglion cells, also referred to as large and polysynaptic. The ganglion cells’ dendrites synapse with retinal bipolar and amacrine cells and the axons synapse with cells in the lateral geniculate body.
The ganglion cell axons course through the inner retina toward the optic nerve forming the nerve fiber layer. They remain unmyelinated until they reach the lamina cribrosa. Axons are in direct contact with each other without interposed glial cells, except for interdigitating Muller cell processes. The axons assume a generally radial course toward the optic nerve except for those immediately temporal to the disc, which form the papillomacular bundle. Since these axons are the first to develop, they form the center of the optic nerve. As axons converge at the optic nerves, the nerve fiber layer becomes thickest; it is thinnest over the macula and far periphery. As is true with all neurons, the axons cannot survive when detached from the cell bodies.11 Both proximal and distal degenerations are seen after acute retinal or optic nerve ischemia; funduscopically, this can be seen as cotton wool spots or optic disc edema. Though long believed to represent focal infarctions of the retinal nerve fiber layer, cotton wool spots may actually be boundary sentinels of inner retinal ischemia.12 Following axonal degeneration, defects in the nerve fiber layer can be seen on OCT or funduscopy.
Muller cells form tight junctions with other Muller cells and neural cells. In the outer retina a continuous row of zonulae adherentes forms the outer limiting membrane, a barrier to metabolite movement into and out of the retina.13 Muller cells constitute the majority of retinal glial cells but the astrocytes are more widely distributed between blood vessels and neurons.
1.1.4 Intercellular Spaces
Neural cells within the retina lie 10–20 mm apart, similar to spacing found in the brain. The intercellular
1 Pathophysiology of Diabetic Retinopathy |
7 |
|
|
spaces are filled with low-density material that does not limit the diffusion of even large proteins.14 Large molecules move freely through the retina until reaching the external limiting membrane; intercellular spaces outside the ELM constitute the subretinal space – referred to as the interphotoreceptor matrix
– comprising glycosaminoglycans, glycoproteins, and filamentous structures.15 The most common interreceptor matrix protein is interstitial retinalbinding protein (IRBP), synthesized and secreted by rod photoreceptor cells. It binds all-trans retinal and 11-cis retinal. Little is known about other matrix proteins.
1.1.5 Internal Limiting Membrane
The ILM is the retina’s only true basement membrane. The outer portion consists of the basement membrane of the Muller cells, whereas the inner portion is formed by vitreous fibrils and mucopolysaccharides. It consists of laminin, BM proteoglycans, fibronectin, and collagen.16 The ILM is 2,000 nm thick over the macula but only 20 nm over the fovea, since the density of Muller cells decreases.17 Muller cell processes form a continuous but uneven border of attachment with the ILM. The exact nature of the vitreous attachment to the ILM is not known.
1.1.6 Circulation
The retina has the highest oxygen demand of any tissue in the body and relies on two circulations to meet this: the inner 2/3 of the retina relies on the retinal vasculature and the outer 1/3 relies on the choroidal circulation. The choroidal circulation has a high and variable flow rate, transferring molecules easily with the surrounding tissues, whereas the retinal circulation provides a lower, more constant flow with a high rate of oxygen extraction.18 The central retinal artery supplies the entire circulatory supply for the inner 2/3 of the retina, except for areas served by cilioretinal arteries, which are seen in 20% of eyes.
1.1.7 Arteries
The central retinal artery penetrates the optic nerve about 10 mm posterior to the globe. Its histological structure resembles that of other comparable sized arteries: a luminal diameter of 200 mm, a wall thickness of 35 mm, a single layer of endothelial cells, a subendothelial elastica, an internal elastic lamina, a medium of smooth muscle, and an external elastic lamina that merges with the adventitia. Degenerative diseases that affect muscular arteries, such as atherosclerosis and giant cell arteritis, also affect the intraneural retinal artery. The arteries within the retina are spared from giant cell arteritis because they lack an internal elastic lamina. Atherosclerosis, with its subendothelial plaque formation and hyperplasia of the intimal and endothelial layers, can affect any portion of the retinal artery. When the artery enters the eye, the elastic lamina is lost but the muscularis is unusually prominent.
The retinal circulation is autoregulated by tissue oxygen concentration, metabolic by-products, and intraocular and systemic blood pressures.19 It is unclear whether the retinal arteries are innervated by sympathetic or parasympathetic nerves but studies suggest that adrenergic-binding sites exist and that retinal blood flow can be altered by adrenergic agonists and antagonists.20,21 After entering the eye the retinal artery divides into superior and inferior branches, then to smaller branches with either dichotomous (equal-sized bifurcation) or side-arm branching. In smaller branches of the artery, the muscular layer thins from seven cell layers at the disc to two layers at the equator and the luminal diameter thins from 120 mm at the disc to 8–15 mm at the equator. The endothelial cells contain tight junctions that prevent the passage of large molecules into or out of the vascular lumens22; therefore, transfer of materials is limited to diffusion and endothelial pinocytosis. The arteries lie in the nerve fiber layer or ganglion cell layer, with only the smaller arterioles descending into the inner plexiform layer to supply capillaries.23 There exist strong connections between the arteries and cortical collagen in the ILM. Traction on the ILM can cause elevation of the retinal arteries without deeper retina traction. The arteries generally lie superficial to the veins but may lie as deep as the inner nuclear
